Comparison of the effects of antioxidant non-steroidal anti-inflammatory drugs against myeloperoxidase and hypochlorous acid luminol-enhanced chemiluminescence
- PMID: 6282074
- DOI: 10.1007/BF01965152
Comparison of the effects of antioxidant non-steroidal anti-inflammatory drugs against myeloperoxidase and hypochlorous acid luminol-enhanced chemiluminescence
Abstract
The interaction of myeloperoxidase (MPO) with H2O2 and Cl- provides a potent antimicrobial/cytotoxic system for polymorphonuclear leukocytes (PMNs). MPO-related cytotoxicity may be associated with the formation of toxic oxidant MPO intermediates, HOCl, or both. MPO itself is able to oxidize drugs and cellular components. Non-steroidal anti-inflammatory drugs (NSAIDs) able to act as antioxidant free radical scavengers have recently been shown to inhibit luminol-enhanced chemiluminescence (CL) which results from the MPO-H2O2-Cl- reaction. CL is a measure of the activity of this reaction. At that time it was not clear whether the source of CL which these NSAIDs affected was HOCl or components of the initial MPO-H2O2-Cl- reaction. A NSAID antioxidant mechanism could affect MPO oxidant intermediates and HOCl. This study compares the effects of antioxidant NSAIDs, methylprednisone and free radical scavengers against MPO-based and NaOCl-based luminol-enhanced CL. Most NSAIDs which affected both MPO and NaOCl-CL appeared to share similar mechanisms, suggesting that MPO oxidant intermediates and HOCl are susceptible to NSAID effects. However, most NSAIDs were more effective against MPO-CL. The effect of these NSAIDs against MPO-CL followed the profile of NSAIDs effective in previous studies against PMN-CL. One exception to this was methylprednisone, which has no effect on PMN or MPO-CL, yet inhibited NaOCl-CL. This and other data suggest that MPO and not HOCl-related reactions are a major source of PMN-CL. Less effective NSAIDs affected NaOCl-CL better than MPO-CL. While both HOCl and MPO oxidant intermediates may be affected by NSAIDs, it appears that MPO oxidant intermediates or MPO itself are the primary target for NSAID antioxidant free radical scavenging mechanisms. These antioxidant effects impair the major killing system of the PMN and may be NSAIDs' primary anti-inflammatory mechanism. Although our data suggests the production of superoxide anion and hydroxyl radical from the MPO-H2O2-Cl- reaction, the actual presence or involvement of these free radical species is not confirmed herein.
Similar articles
-
Antioxidation theory of non-steroidal anti-inflammatory drugs based upon the inhibition of luminol-enhanced chemiluminescence from the myeloperoxidase reaction.Agents Actions. 1982 Jul;12(3):371-6. doi: 10.1007/BF01965406. Agents Actions. 1982. PMID: 6291348
-
Oxidation of desferrioxamine to nitroxide free radical by activated human neutrophils.Free Radic Biol Med. 1993 Jun;14(6):589-99. doi: 10.1016/0891-5849(93)90140-p. Free Radic Biol Med. 1993. PMID: 7686874
-
Inhibition of the myeloperoxidase-H2O2-Cl- system of neutrophils by indomethacin and other non-steroidal anti-inflammatory drugs.Biochem Pharmacol. 1991 Mar 15-Apr 1;41(6-7):975-84. doi: 10.1016/0006-2952(91)90204-i. Biochem Pharmacol. 1991. PMID: 1848981
-
The reactions of hypochlorous acid, the reactive oxygen species produced by myeloperoxidase, with lipids.Acta Biochim Pol. 2000;47(4):889-99. Acta Biochim Pol. 2000. PMID: 11996112 Review.
-
Neutrophil dysfunction in the pathogenesis of cystic fibrosis.Blood. 2022 Apr 28;139(17):2622-2631. doi: 10.1182/blood.2021014699. Blood. 2022. PMID: 35213685 Free PMC article. Review.
Cited by
-
The reactivity of neutrophils at the site of an acute inflammatory reaction as measured by chemiluminescence.Agents Actions. 1984 Oct;15(3-4):349-55. doi: 10.1007/BF01972370. Agents Actions. 1984. PMID: 6524524
-
Retinoids inhibit the respiratory burst and degranulation of stimulated human polymorphonuclear leukocytes.Agents Actions. 1991 Nov;34(3-4):339-44. doi: 10.1007/BF01988726. Agents Actions. 1991. PMID: 1667243
-
Naphthalenes as inhibitors of myeloperoxidase: direct and indirect mechanisms of inhibition.Agents Actions. 1990 Mar;29(3-4):266-76. doi: 10.1007/BF01966457. Agents Actions. 1990. PMID: 2160187
-
Mechanism of action of 5-arninosalicylic acid.Mediators Inflamm. 1992;1(3):151-65. doi: 10.1155/S0962935192000243. Mediators Inflamm. 1992. PMID: 18475455 Free PMC article.
-
Perioperative aspirin improves neurological outcome after focal brain ischemia possibly via inhibition of Notch 1 in rat.J Neuroinflammation. 2014 Mar 25;11:56. doi: 10.1186/1742-2094-11-56. J Neuroinflammation. 2014. PMID: 24661619 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Research Materials
Miscellaneous